Nuclear Engineering
Researchers from University Hospital, Department of Nuclear Medicine detail findings in nuclear engineering
Published in Cancer Weekly, July 13th, 2010
New research, 'Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial,' is the subject of a report. According to recent research from Muenster, Germany, "The Multicentre Study Differentiated Thyroid Cancer (MSDS) collective represents a well defined group of patients with locally aggressive thyroid carcinomas (pT4; AJCC/UICC 1997). The aim of the present study was to compare the survival of patients with minimum and extensive extrathyroidal growth according to the new AJCC/UICC TNM staging system 2009."
"The follow-up data of 347 patients were analysed. Patients were reclassified according to the current...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-07-13)
More Articles from Cancer Weekly
- American Society for Radiation Oncology
ASTRO patient education program recognized by AAA Awards - Prostate Cancer
Be Bold, Be Bald! To Help Fight Cancer & Honor Patients - Head and Neck Cancer
Coffee may protect against head and neck cancers - Cancer Research
Data from M. Malvezzi and colleagues advance knowledge in cancer research - Family Medicine
Data from Oregon Health Sciences University provide new insights into family medicine - Angiogenesis
Data from University Hospital provide new insights into angiogenesis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
